NO994659L - Nye pyridinderivater og farmasöytiske preparater inneholdende slike - Google Patents
Nye pyridinderivater og farmasöytiske preparater inneholdende slikeInfo
- Publication number
- NO994659L NO994659L NO994659A NO994659A NO994659L NO 994659 L NO994659 L NO 994659L NO 994659 A NO994659 A NO 994659A NO 994659 A NO994659 A NO 994659A NO 994659 L NO994659 L NO 994659L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical preparations
- preparations containing
- pyridine derivatives
- new pyridine
- cycloalkyl
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 150000003222 pyridines Chemical class 0.000 title 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9701100A SE9701100D0 (sv) | 1997-03-25 | 1997-03-25 | Novel compounds |
| SE9702199A SE9702199D0 (sv) | 1997-06-09 | 1997-06-09 | Novel compounds |
| SE9704403A SE9704403D0 (sv) | 1997-11-28 | 1997-11-28 | Novel compounds |
| PCT/SE1998/000505 WO1998042670A1 (en) | 1997-03-25 | 1998-03-20 | Novel pyridine derivatives and pharmaceutical compositions containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO994659D0 NO994659D0 (no) | 1999-09-24 |
| NO994659L true NO994659L (no) | 1999-11-25 |
Family
ID=27355863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO994659A NO994659L (no) | 1997-03-25 | 1999-09-24 | Nye pyridinderivater og farmasöytiske preparater inneholdende slike |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6300352B1 (es) |
| EP (1) | EP0971892A1 (es) |
| JP (1) | JP2001518115A (es) |
| KR (1) | KR20010005646A (es) |
| CN (1) | CN1257481A (es) |
| AR (1) | AR012157A1 (es) |
| AU (1) | AU6530998A (es) |
| BR (1) | BR9808042A (es) |
| CA (1) | CA2284200A1 (es) |
| EE (1) | EE9900426A (es) |
| ID (1) | ID22660A (es) |
| IL (1) | IL131846A0 (es) |
| NO (1) | NO994659L (es) |
| PL (1) | PL335905A1 (es) |
| SK (1) | SK130599A3 (es) |
| TR (1) | TR199902350T2 (es) |
| WO (1) | WO1998042670A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6521618B2 (en) | 2000-03-28 | 2003-02-18 | Wyeth | 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| US6376524B1 (en) | 2000-06-21 | 2002-04-23 | Sunesis Pharmaceuticals, Inc. | Triphenyl compounds as interleukin-4 antagonists |
| US7338969B2 (en) * | 2002-03-08 | 2008-03-04 | Quonova, Llc | Modulation of pathogenicity |
| US7335779B2 (en) * | 2002-03-08 | 2008-02-26 | Quonova, Llc | Modulation of pathogenicity |
| US7153889B2 (en) * | 2002-11-12 | 2006-12-26 | Abbott Laboratories | Bicyclic-substituted amines as histamine-3 receptor ligands |
| CA2505427C (en) * | 2002-11-12 | 2012-04-03 | Abbott Laboratories | Bicyclic-substituted amines as histamine-3 receptor ligands |
| US20040092521A1 (en) * | 2002-11-12 | 2004-05-13 | Altenbach Robert J. | Bicyclic-substituted amines as histamine-3 receptor ligands |
| US20070197492A1 (en) * | 2003-05-06 | 2007-08-23 | Aldo Ammendola | Modulation of Pathogenicity |
| EP1778214A4 (en) * | 2004-07-27 | 2010-04-14 | Glaxosmithkline Llc | NEW BIPHENYL COMPOUNDS AND THEIR USE |
| US7498049B1 (en) * | 2007-01-03 | 2009-03-03 | Shmuel Gonen | Topical treatment of acne with combined herbal extracts and minerals |
| ES2879826T3 (es) | 2015-06-15 | 2021-11-23 | Nmd Pharma As | Compuestos para su uso en el tratamiento de trastornos neuromusculares |
| US11730714B2 (en) | 2017-12-14 | 2023-08-22 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
| US11147788B2 (en) | 2017-12-14 | 2021-10-19 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
| SI3921030T1 (sl) * | 2019-02-06 | 2024-03-29 | Eli Lilly And Company | Derivati 1-((2-(2,2,2-trifluoroetoksi)piridin-4-il)metil)sečnine kot ojačevalci kcnq |
| CN114989114A (zh) * | 2022-06-02 | 2022-09-02 | 杭州福斯特电子材料有限公司 | 一种n-丙烯酰吗啉的合成方法及光固化组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7955287A (en) | 1986-10-14 | 1988-04-21 | G.D. Searle & Co. | Pyridine derivatives |
| EP0264114A1 (en) | 1986-10-16 | 1988-04-20 | G.D. Searle & Co. | Alpha-[(phenylmethoxy)methyl]pyridine-alkanol derivatives |
| EE9800172A (et) | 1995-12-06 | 1998-12-15 | Astra Pharmaceuticals Limited | Ühendid |
-
1998
- 1998-03-20 AU AU65309/98A patent/AU6530998A/en not_active Abandoned
- 1998-03-20 EP EP98911337A patent/EP0971892A1/en not_active Ceased
- 1998-03-20 PL PL98335905A patent/PL335905A1/xx unknown
- 1998-03-20 TR TR1999/02350T patent/TR199902350T2/xx unknown
- 1998-03-20 WO PCT/SE1998/000505 patent/WO1998042670A1/en not_active Application Discontinuation
- 1998-03-20 CA CA002284200A patent/CA2284200A1/en not_active Abandoned
- 1998-03-20 KR KR1019997008714A patent/KR20010005646A/ko not_active Application Discontinuation
- 1998-03-20 JP JP54555898A patent/JP2001518115A/ja active Pending
- 1998-03-20 US US09/068,522 patent/US6300352B1/en not_active Expired - Fee Related
- 1998-03-20 ID IDW991080A patent/ID22660A/id unknown
- 1998-03-20 SK SK1305-99A patent/SK130599A3/sk unknown
- 1998-03-20 BR BR9808042-3A patent/BR9808042A/pt not_active IP Right Cessation
- 1998-03-20 EE EEP199900426A patent/EE9900426A/xx unknown
- 1998-03-20 IL IL13184698A patent/IL131846A0/xx unknown
- 1998-03-20 CN CN98805262A patent/CN1257481A/zh active Pending
- 1998-03-24 AR ARP980101343A patent/AR012157A1/es unknown
-
1999
- 1999-09-24 NO NO994659A patent/NO994659L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ID22660A (id) | 1999-12-02 |
| PL335905A1 (en) | 2000-05-22 |
| SK130599A3 (en) | 2000-05-16 |
| CA2284200A1 (en) | 1998-10-01 |
| AR012157A1 (es) | 2000-09-27 |
| CN1257481A (zh) | 2000-06-21 |
| US6300352B1 (en) | 2001-10-09 |
| EE9900426A (et) | 2000-04-17 |
| BR9808042A (pt) | 2000-03-08 |
| WO1998042670A1 (en) | 1998-10-01 |
| JP2001518115A (ja) | 2001-10-09 |
| IL131846A0 (en) | 2001-03-19 |
| TR199902350T2 (xx) | 2000-04-21 |
| KR20010005646A (ko) | 2001-01-15 |
| NO994659D0 (no) | 1999-09-24 |
| EP0971892A1 (en) | 2000-01-19 |
| AU6530998A (en) | 1998-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO994659L (no) | Nye pyridinderivater og farmasöytiske preparater inneholdende slike | |
| DE69416501D1 (de) | 2-propylvaleriansäure und 2-propylvalerian-säureamid-derivate und deren verwendung als antikonvulsive mittel | |
| TR199901578T2 (xx) | Klaritromisin form 0 kristali | |
| ES8704473A1 (es) | Procedimiento para la produccion de derivados de la 13-beta-milbemicina | |
| AP9701039A0 (en) | Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one. | |
| TW427887B (en) | Pharmaceutical composition comprising a benzimidazole derivative for treating viral infections | |
| PH25859A (en) | Composition for treatment of ischemic disorder | |
| DE69505968D1 (de) | Azolidindion-derivate und ihre anwendung als antihyperglykämika | |
| HUT75111A (en) | Use of pyridyl-,oxadiazole or thiadiazole derivatives for producing pharmaceutical compositions having effect | |
| NO304379B1 (no) | 11,21-bisfenyl-19-norpregnan-derivater, anvendelse derav og farmas°ytiske preparater inneholdende slike derivater | |
| CA2013037A1 (en) | Aminobenzenesulfonic acid derivative | |
| CA2103590A1 (en) | Benzamide derivative | |
| DE69429570D1 (de) | Galanthamin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente | |
| AU5162396A (en) | Protective agent for organ or tissue | |
| AU7414691A (en) | New 3-aminochroman derivatives, process for preparing these and pharmaceutical compositions containing them | |
| NO994764L (no) | Nye pyridinderivater og farmasöytiske preparater inneholdende disse | |
| HUP9903526A2 (hu) | Pirimidinszármazékok és az ezeket tartalmazó gyógyszerkészítmények | |
| ES8300096A1 (es) | "un procedimiento para preparar derivados de halofenil-piridil-alilamina". | |
| ES8600224A1 (es) | Procedimiento de preparacion de nuevos derivados carbamiloxibenzoles | |
| AU655869B2 (en) | An amphoteric tricyclic compound | |
| EA199900460A1 (ru) | Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные | |
| ES8604843A1 (es) | Un metodo para la preparacion de un derivado de acetileno | |
| ES8300776A1 (es) | Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a)pirimidina | |
| IL95377A0 (en) | Therapeutic agent for the treatment of peptic ulcer disease containing xanthine derivatives and some novel compounds of this type | |
| ES8505653A1 (es) | Procedimiento para preparar un n-alquil-(3 o 4)piperidinil benzoato |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |